Skip to Content

What is Mektovi used to treat?

Answers (1)

Official Answer by 23 Aug 2018
Mektovi (binimetinib) from Array BioPharma, along with Braftovi (encorafenib), is part of an oral BRAF/MEK inhibitor combination therapy used for patients with unresectable or metastatic melanoma (skin cancer that has spread) with a BRAF V600E or V600K gene mutation, as detected by an FDA-approved test. Both Braftovi and Mektovi are kinase inhibitors. Roughly 50% of patients diagnosed with metastatic melanoma test positive for the BRAF mutation, and it is the most common genetic mutation in metastatic melanoma. free discount card

Further Information

Search for questions

Still looking for answers? Try searching for what you seek or ask your own question.

Frequently Asked Questions

What disease is Elzonris (tagraxofusp-erzs) used to treat?

Updated 7 Jan 2019 1 answerFAQ by

How do you use the ProAir Digihaler?

Updated 7 Jan 2019 1 answerFAQ by

How many biosimilars have been approved in the United States?

Updated 8 Jan 2019 1 answerFAQ by

What are the brands of sumatriptan?

Updated 5 Feb 2019 1 answerFAQ by

What is botulinum toxin used to treat?

Updated 14 Feb 2019 1 answerFAQ by